ArticleAcademic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry2026
Knowing When to Stop: Navigating Polypharmacy Training in Geriatric Psychiatry.
Article in Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo explore psychiatry residents' experiences, challenges, and perceived educational gaps in managing polypharmacy among older adults within a large academic hospital setting.
methodsUsing a qualitative descriptive approach, we synthesized recurring themes and insights emerging from longitudinal clinical reflections, supervision discussions, and interdisciplinary educational forums conducted over a 12-month academic year, including monthly group supervision sessions and weekly faculty supervision during routine clinical rotations. Additional perspectives were informed by interdisciplinary grand rounds focused on geriatric care. Discussions emphasized clinical dilemmas related to medication safety, transitions of care, and regulatory knowledge. A focused literature review contextualized these observations within current geriatric psychiatry training practices.
resultsResidents commonly encountered neuropsychiatric symptoms attributed to polypharmacy, including agitation, delirium, and cognitive impairment. High-risk medications and incomplete reconciliation were prevalent during care transitions. System-level issues such as non-specific electronic health record alerts, limited pharmacist engagement, and variable handoff protocols were noted. Educational deficits included minimal formal instruction on deprescribing tools (e.g., Beers Criteria, STOPP/START), regulatory requirements, and communication strategies with families and caregivers. Mentorship from geriatric-trained psychiatrists was scarce, contributing to low subspecialty engagement.
conclusionsDespite growing responsibilities in geriatric care, psychiatry residents often lack adequate training in polypharmacy management. Findings underscore the need for structured curricula incorporating deprescribing frameworks, regulatory education, and interdisciplinary collaboration. Addressing these gaps is critical for improving medication safety and preparing the next generation of psychiatrists to serve an aging population.
Indexed as
Identifiers
41922854What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.